Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Demand for elastomeric infusion pumps is accelerating on clinician convenience, home-care growth, sustainable materials ...

Smiths Medical also identified three issues associated with the potential for thermal damage in affected infusion pumps. If certain parts of the pump are damaged, heat can melt the plastic housing to ...

As radiopharmaceutical therapies gain momentum, new challenges are emerging in how they’re administered—especially around ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, expects the India infusion pumps market size to grow at a CAGR of 8.26% during the forecast period between ...

The FDA issued three notices identifying warnings sent out by ICU Medical's Smiths Medical unit related to infusion pump problems.

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death.

The company will offer a fresh issue of shares aggregating up to Rs 890 crore for the initial public offering.

Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

This advanced, MRI-compatible infusion pump extends Iradimed’s unique position as the world’s only supplier of non-magnetic MRI infusion pump devices, established with our first-generation ...